DK1112067T3 - Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer - Google Patents

Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer

Info

Publication number: DK1112067T3
Authority: DK; Denmark
Prior art keywords: treatment; functional; preparation; pain syndromes; pharmaceutical compositions
Prior art date: 1998-09-11

Application number

DK99946150T

Other languages

Danish (da)

English (en)

Inventor

Maria Nicolodi

Federigo Sicuteri

Original Assignee

Eisai Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-11

Filing date

1999-09-09

Publication date

2006-09-04

1999-09-09 Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd

2006-09-04 Application granted granted Critical

2006-09-04 Publication of DK1112067T3 publication Critical patent/DK1112067T3/da

Links

239000000544 cholinesterase inhibitor Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
208000011580 syndromic disease Diseases 0.000 title 1
ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 abstract 2
206010064012 Central pain syndrome Diseases 0.000 abstract 1
208000001640 Fibromyalgia Diseases 0.000 abstract 1
208000019695 Migraine disease Diseases 0.000 abstract 1
208000004983 Phantom Limb Diseases 0.000 abstract 1
238000002266 amputation Methods 0.000 abstract 1
230000001363 autoimmune Effects 0.000 abstract 1
230000002638 denervation Effects 0.000 abstract 1
229960003530 donepezil Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
206010027599 migraine Diseases 0.000 abstract 1
230000000472 traumatic effect Effects 0.000 abstract 1
230000001173 tumoral effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK99946150T 1998-09-11 1999-09-09 Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer DK1112067T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT1998FI000208A IT1304904B1 (it)	1998-09-11	1998-09-11	Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche

Publications (1)

Publication Number	Publication Date
DK1112067T3 true DK1112067T3 (da)	2006-09-04

Family

ID=11352669

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99946150T DK1112067T3 (da)	1998-09-11	1999-09-09	Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer

Country Status (12)

Country	Link
US (1)	US6608088B1 (de)
EP (1)	EP1112067B1 (de)
JP (1)	JP3984787B2 (de)
AT (1)	ATE327740T1 (de)
AU (1)	AU5861799A (de)
CY (1)	CY1105125T1 (de)
DE (1)	DE69931640T2 (de)
DK (1)	DK1112067T3 (de)
ES (1)	ES2265691T3 (de)
IT (1)	IT1304904B1 (de)
PT (1)	PT1112067E (de)
WO (1)	WO2000015205A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001066114A1 (en)	2000-03-03	2001-09-13	Eisai Co., Ltd.	Novel methods using cholinesterase inhibitors
US20060183776A9 (en) *	2000-03-03	2006-08-17	Eisai Co., Ltd.	Liquid dosage formulations of donepezil
KR20020089510A (ko) *	2000-04-21	2002-11-29	파마시아 앤드 업존 캄파니	섬유 근육통 증후군 및 만성 피로 증후군의 치료
WO2002083141A1 (en) *	2001-04-17	2002-10-24	Pharmacia & Upjohn Company	Treatment of fibromyalgia and chronic fatigue syndrome
AT500143A1 (de) *	2004-04-22	2005-11-15	Sanochemia Pharmazeutika Ag	Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung
AU2006209216A1 (en)	2005-01-25	2006-08-03	Galenea Corp	Substituted arylamine compounds and their use as 5-HT6 modulators
CA2597566A1 (en) *	2005-02-11	2006-08-17	Stephen Wills	Treating microvasculature diseases with acetyl cholinesterase inhibitors
ATE511843T1 (de) *	2005-04-04	2011-06-15	Eisai R&D Man Co Ltd	Dihydropyridin-verbindungen für neurodegenerative erkrankungen und demenz
EP2044937A4 (de)	2006-07-05	2010-10-27	Tianjin Hemay Bio Tech Co Ltd	Analgetische 5,9-methanocycloocta (b) pyridin-2(1h)-on-derivate, ihr herstellungsverfahren und verwendung
US8012994B1 (en)	2006-09-22	2011-09-06	Sevastyanov Victor V	Method for the treatment of sensorineural hearing loss with donepezil hydrochloride (ARICEPT®)
US8278345B2 (en)	2006-11-09	2012-10-02	Probiodrug Ag	Inhibitors of glutaminyl cyclase
JP5523107B2 (ja)	2006-11-30	2014-06-18	プロビオドルグエージー	グルタミニルシクラーゼの新規阻害剤
EP2481408A3 (de)	2007-03-01	2013-01-09	Probiodrug AG	Neue Verwendung von Inhibitoren der Glutaminyl Cyclase
WO2008128985A1 (en)	2007-04-18	2008-10-30	Probiodrug Ag	Thiourea derivatives as glutaminyl cyclase inhibitors
US8138169B2 (en)	2008-04-11	2012-03-20	Comgenrx, Inc.	Combination therapy for bipolar disorder
MX2012002993A (es)	2009-09-11	2012-04-19	Probiodrug Ag	Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
US20110212928A1 (en)	2010-02-09	2011-09-01	The Johns Hopkins University	Methods and compositions for improving cognitive function
JP6026284B2 (ja)	2010-03-03	2016-11-16	プロビオドルグエージー	グルタミニルシクラーゼの阻害剤
US8269019B2 (en)	2010-03-10	2012-09-18	Probiodrug Ag	Inhibitors
WO2011131748A2 (en)	2010-04-21	2011-10-27	Probiodrug Ag	Novel inhibitors
WO2011151359A1 (en)	2010-06-02	2011-12-08	Noscira, S.A.	Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
ES2570167T3 (es)	2011-03-16	2016-05-17	Probiodrug Ag	Derivados de benzimidazol como inhibidores de glutaminil ciclasa
JP2015078129A (ja) *	2012-02-01	2015-04-23	株式会社新日本科学	ドネペジルを含む線維筋痛症の治療剤
WO2014078568A1 (en)	2012-11-14	2014-05-22	The Johns Hopkins University	Methods and compositions for treating schizophrenia
EP2968220B1 (de)	2013-03-15	2021-05-05	Agenebio, Inc.	Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen
WO2014144663A1 (en)	2013-03-15	2014-09-18	The Johns Hopkins University	Methods and compositions for improving cognitive function
NZ738682A (en)	2015-05-22	2022-01-28	Agenebio Inc	Extended release pharmaceutical compositions of levetiracetam
PL3461819T3 (pl)	2017-09-29	2020-11-30	Probiodrug Ag	Inhibitory cyklazy glutaminylowej

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5010083A (en)	1988-03-28	1991-04-23	Hoechst-Roussel Pharmaceuticals, Inc.	2,6-methano-1,3-benzodiazocine compounds which have useful pharmaceutical utility
DE3927049A1 (de)	1989-08-16	1991-02-21	Sandoz Ag	Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung
US5336675A (en) *	1991-05-14	1994-08-09	Ernir Snorrason	Method of treating mania in humans
GB9606736D0 (en) *	1996-02-19	1996-06-05	Shire International Licensing	Therapeutic method
AU8742198A (en) *	1997-08-15	1999-03-08	Shire International Licensing B.V.	Use of cholinesterase inhibitor for treating diseases associated with pro teolytic enzyme activity

1998
- 1998-09-11 IT IT1998FI000208A patent/IT1304904B1/it active
1999
- 1999-09-09 DK DK99946150T patent/DK1112067T3/da active
- 1999-09-09 AU AU58617/99A patent/AU5861799A/en not_active Abandoned
- 1999-09-09 US US09/763,751 patent/US6608088B1/en not_active Expired - Fee Related
- 1999-09-09 PT PT99946150T patent/PT1112067E/pt unknown
- 1999-09-09 DE DE69931640T patent/DE69931640T2/de not_active Expired - Lifetime
- 1999-09-09 WO PCT/EP1999/006648 patent/WO2000015205A2/en not_active Ceased
- 1999-09-09 EP EP99946150A patent/EP1112067B1/de not_active Expired - Lifetime
- 1999-09-09 JP JP2000569789A patent/JP3984787B2/ja not_active Expired - Fee Related
- 1999-09-09 ES ES99946150T patent/ES2265691T3/es not_active Expired - Lifetime
- 1999-09-09 AT AT99946150T patent/ATE327740T1/de active
2006
- 2006-08-07 CY CY20061101098T patent/CY1105125T1/el unknown

Also Published As

Publication number	Publication date
ATE327740T1 (de)	2006-06-15
DE69931640T2 (de)	2007-03-08
US6608088B1 (en)	2003-08-19
WO2000015205A2 (en)	2000-03-23
WO2000015205A3 (en)	2000-08-24
EP1112067A2 (de)	2001-07-04
JP3984787B2 (ja)	2007-10-03
AU5861799A (en)	2000-04-03
CY1105125T1 (el)	2009-11-04
DE69931640D1 (de)	2006-07-06
ES2265691T3 (es)	2007-02-16
PT1112067E (pt)	2006-09-29
ITFI980208A1 (it)	2000-03-11
IT1304904B1 (it)	2001-04-05
ITFI980208A0 (it)	1998-09-11
EP1112067B1 (de)	2006-05-31
JP2002524498A (ja)	2002-08-06

Publication	Publication Date	Title
AU5861799A (en)	2000-04-03	Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes
DK0760848T3 (da)	1998-09-23	Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
YU7797A (sh)	2000-10-30	Kombinovana terapija za osteoporozu
NO962187D0 (no)	1996-05-29	Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav
MY129189A (en)	2007-03-30	Prostaglandin agonists and their use to treat bone disorders
DK1039912T3 (da)	2002-10-28	Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DK1097173T3 (da)	2008-09-01	Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
MY141384A (en)	2010-04-30	Prevention of loss and restoration of bone mass by certain prostaglandin agonists
IS5764A (is)	2000-12-08	Samsetning til að fyrirbyggja og/eða meðhöndla beingisnun og breytingar vegna tíðahvarfa heilkenna
HUP9700603A1 (hu)	1999-06-28	Gyógyászati készítmény véralvadási zavarok kezelésére
DK0951473T3 (da)	2002-09-16	Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
TR199701669A1 (xx)	2001-10-22	Deri preparasyonu i�in bile�imler.
NO985981L (no)	1998-12-18	Insulinpreparater som inneholder NaCl
AP1424A (en)	2005-06-06	2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
AP9801269A0 (en)	1999-12-18	Prostaglandin agonists.
BR9708114A (pt)	2000-01-25	Análogos xantona para o tratamento de doenças infecciosas.
PT1109571E (pt)	2004-05-31	Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
DK1073456T3 (da)	2005-10-24	Anvendelse af osteoprotegerin til forebyggelse og behandling af kardiovaskulære sygdomme
DK0888323T3 (da)	2004-08-09	Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
NO964238D0 (no)	1996-10-04	Halofantrin-fri-base for behandling av malaria og blandinger
PT1282418E (pt)	2005-10-31	Utilizacao de derivados pirazolo para o tratamento da infertilidade
DK0988040T3 (da)	2004-11-29	Anvendelse af glucosamin og glucasamin-derivater til hurtig lindring af klöe eller lokaliseret smerte
NO983177L (no)	1998-07-10	Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
ATE266029T1 (de)	2004-05-15	Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
DK1021519T3 (da)	2003-04-14	Fremgangsmåde til rengøring af kirurgiske instrumenter